ReportAlert.info - Amgen (NASDAQ:AMGN) Publishes 2011 Environmental Sustainability Report

Primary tabs

ReportAlert.info - Amgen (NASDAQ:AMGN) Publishes 2011 Environmental Sustainability Report

The report illustrates how environmental efforts at the company improve business efficiency, benefit communities, and support the company’s mission to develop innovative medicines.
tweet me:
ReportAlert.info - Amgen (NASDAQ:AMGN) Publishes 2011 Environmental Sustainability Report http://3bl.me/cgbezk @ReportAlert @CorpReg #CSR
Tuesday, June 12, 2012 - 2:10pm

CAMPAIGN: ReportAlerts from CorporateRegister.com 2012

CONTENT: Press Release

(3BL Media) June 12, 2012 - Amgen has released its second annual environmental sustainability report highlighting Amgen’s environmental sustainability plan and 2011 results. Amgen’s environmental sustainability plan is reliant on staff ingenuity and drive, combined with a strong culture of continuous improvement. The report illustrates how environmental efforts at Amgen improve business efficiency, benefit communities, and support the company’s mission to develop innovative medicines.

To read Amgen’s report, please visit  environment.amgen.com.

Report highlights:

  • Amgen has exceeded four of six 2012 environmental targets.
  • The company has realized an annualized savings of more than $11 million from energy projects and initiatives.
  • With programs such as Green Biology and Green Chemistry, Amgen is integrating environmental sustainability practices across all the many complex activities it undertakes to serve patients.
  • Amgen’s 2011 report has been confirmed at a “C+” application level by the Global Reporting Initiative. The environmental sustainability data set in the report was verified by Bureau Veritas, an important step in Amgen’s overall environmental sustainability plan.

Amgen is a biotechnology pioneer that discovers, develops, and delivers innovative human therapeutics. Amgen medicines help millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen continues to advance science to serve patients.

Amgen welcomes your feedback at esfeedback@amgen.com

Keywords: Research, Reports & Publications | Amgen | Corporate Responsibility | Pharmaceuticals & Biotechnology | Reporting | Research, Reports & Publications | Responsible Business & Employee Engagement | csr | environment | environmental sustainability | sustainability

CAMPAIGN: ReportAlerts from CorporateRegister.com 2012

CONTENT: Press Release

parse.ly